000			05018cam a22004334i 4500
999			_c7274 _d7274
001			14475488
005			20201025094353.0
008			060728s2007 fluaf b 001 0 eng
010			_a 2006024885
020			_a0849371945 (hardcover : alk. paper)
020			_a9780849371943 (hardcover : alk. paper)
040			_aDNLM/DLC _cDLC _dNLM _dBAKER _dC#P _dYDX _dYDXCP _dDLC _erda
050	0	0	_aRC262 _b.N22 2007
082	0	0	_a616.994061 _222 _bN
245	0	0	_aNanotechnology for cancer therapy / _cedited by Mansoor M. Amiji.
264		1	_aBoca Raton : _bCRC/Taylor & Francis, _c[2007]
264		4	_c©2007
300			_a817 pages, [8] pages of plates : _billustrations (some color) ; _c27 cm
336			_2rdacontent _atext
337			_2rdamedia _aunmediated
338			_2rdacarrier _avolume
504			_aIncludes bibliographical references and index.
505	0		_aSection I. Nanotechnology and Cancer -- Chapter 1. Introduction and Rationale for Nanotechnology in Cancer Therapy. -- Chapter 2. Passive Targeting of Solid Tumors: Pathophysiological Principles and Physicochemical Aspects of Delivery Systems. -- Chapter 3. Active Targeting Strategies in Cancer with a Focus on Potential Nanotechnology Applications -- Chapter 4. Pharmacokinetic Analysis of Nanocarrier-Mediated Drug and Gene Delivery. -- Chapter 5. Multifunctional Nanoparticles for Cancer Therapy. Chapter 6. Neutron Capture Therapy of Cancer: Nanoparticles and High Molecular Weight Boron Delivery Agents. -- Chapter 7. Preclinical Characterization of Engineered Nanoparticles Intended for Cancer Therapeutics.-- Chapter 8. Nanotechnology: Regulatory Perspective for Drug Development in Cancer Therapeutics. -- Section II. Polymer Conjugates -- Chapter 9. Polymeric Conjugates for Angiogenesis Targeted Tumor Imaging and Therapy. -- Chapter 10. Poly(L-glutamic acid): Efficient Carrier of Cancer Therapeutics and Diagnostics. -- Chapter 11. Non-Invasive Visualization of In Vivo Drug Delivery of Paramagnetic Polymer Conjugates with MRI .-- Section III. Polymeric Nanoparticles -- Chapter 12. Polymeric Nanoparticles for Tumor-Targeted Drug Delivery. -- Chapter 13. Long-circulating Polymeric Nanocarriers for Drug and Gene Delivery to Tumors -- Chapter 14. Biodegradable PLGA/PLA Nanoparticles for Anticancer Therapy. -- Chapter 15. Poly(alkyl cyanoacrylate) Nanoparticles for Delivery of Anticancer Drugs. -- Chapter 16. Aptamers and Cancer Nanotechnology. -- Section IV. Polymeric Micelles -- Chapter 17. Polymeric Micelles for Formulation of Anticancer Drugs. -- Chapter 18. PEO-Modified Poly(L-amino acid) Micelles for Drug Delivery. -- Chapter 19. Hydrotropic Polymer Micellar for Cancer Therapeutics. -- Chapter 20. Tumor-targeted delivery of sparingly-soluble anticancer drugs with polymeric lipid-core immunomicelles. -- Chapter 21. Combined Cancer Therapy by Micellar-Encapsulated Drug and Ultrasound. -- Chapter 22. Polymeric Micelles for Targeting Tumor pH. -- Chapter 23. cRGD-Encoded, MRI-Visible Polymeric Micelles for Tumor-Targeted Drug Delivery. -- Chapter 24. Targeted Antisense Oligonucleotide Micellar Delivery Systems. -- Section V. Dendritic Nanocarriers -- Chapter 25. Dendrimers in Drug and Gene Delivery. -- Chapter 26. Dendritic Nanostructures for Cancer Therapy. -- Chapter 27. PEGylated Dendritic Nanoparticulate Carriers of Anticancer Drug. -- Chapter 28. Dendrimer Nanocomposites for Cancer Therapy. -- Section VI. Liposomes -- Chapter 29. Applications of Liposomal Drug Delivery Systems to Cancer Therapy. -- Chapter 30. Positively-Charged Liposomes for Targeting Tumor -- Chapter 31. Cell Penetrating Peptide (CPP)-Modified Liposomal Nanocarriers for Intracellular Drug and Gene Delivery. -- Chapter 32. RGD-Modified Liposomes for Tumor Targeting. S.P. Vyas -- Chapter 33. Folate Receptor-Targeted Liposomes for Cancer Therapy. -- Chapter 34. Nanoscale Drug Delivery Vehicles for Solid Tumors: A New Paradigm for Localized Drug Delivery Using Temperature Sensitive Liposomes. -- Section VII. Other Lipid Nanostructures -- Chapter 35. Nanoemulsions for Tumor Targeted Delivery. -- Chapter 36. Solid-Lipid Nanoparticles for Antitumor Drug Delivery. -- Chapter 37. Lipoprotein Nanoparticles as Delivery Vehicles for Anti-cancer Therapy. -- Chapter 38. DQAsomes as Mitochondria-Targeted Nano-Carriers for Anticancer Drugs.
650		0	_aCancer.
650		0	_aNanotechnology.
650		0	_aDrug targeting.
650		0	_aAntineoplastic agents.
650	1	2	_aNeoplasms _xtherapy.
650	2	2	_aDrug Delivery Systems.
650	2	2	_aNanotechnology.
650	2	2	_aNeoplasms _xdiagnosis.
700	1		_aAmiji, Mansoor M. _eeditor.
856	4	1	_3Table of contents only _uhttp://www.loc.gov/catdir/toc/ecip0618/2006024885.html
856	4	2	_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0664/2006024885-d.html
856	4	2	_3Abstract _uhttp://repository.fue.edu.eg/xmlui/handle/123456789/1667
942			_cBK _2ddc